| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 干混悬剂(元) | - | 4,174,274.62 | - | 5,197,173.84 |
| 胶囊剂(元) | 524,772.31 | 273,206.66 | 694,306.64 | 345,339.81 |
| 颗粒剂(元) | 25,547,014.18 | 13,346,515.85 | 24,131,838.97 | 13,655,721.63 |
| 口服液(元) | 39,604,908.84 | 17,780,555.95 | 41,901,649.33 | 26,539,924.62 |
| 片剂(元) | 24,398,997.79 | 9,160,887.41 | 28,466,901.22 | 13,370,250.38 |
| 原料药(元) | 1,687,779.26 | 742,646.01 | 10,106,918.40 | 6,422,655.57 |
| 注射剂(元) | 110,386,018.65 | 58,020,676.24 | 109,163,055.61 | 47,232,931.07 |
| 干悬混剂(元) | 7,498,372.25 | - | 9,608,754.85 | - |
| 营业成本(元) | ||||
| 干混悬剂(元) | - | 3,223,369.07 | - | 4,011,186.72 |
| 胶囊剂(元) | 23,784.74 | 12,145.09 | 44,703.55 | 11,057.44 |
| 颗粒剂(元) | 17,084,554.95 | 9,170,475.48 | 16,366,572.50 | 9,170,310.49 |
| 口服液(元) | 28,397,663.67 | 12,946,542.83 | 27,555,693.77 | 15,286,465.03 |
| 片剂(元) | 18,067,775.09 | 5,416,999.71 | 20,042,173.36 | 9,081,510.36 |
| 原料药(元) | 1,808,711.85 | 643,133.88 | 9,111,235.11 | 5,559,188.93 |
| 注射剂(元) | 92,713,111.50 | 48,976,817.67 | 78,767,171.97 | 30,719,030.64 |
| 干悬混剂(元) | 5,872,135.28 | - | 7,429,039.12 | - |
| 毛利(元) | ||||
| 干混悬剂(元) | - | 950,905.55 | - | 1,185,987.12 |
| 胶囊剂(元) | 500,987.57 | 261,061.57 | 649,603.09 | 334,282.37 |
| 颗粒剂(元) | 8,462,459.23 | 4,176,040.37 | 7,765,266.47 | 4,485,411.14 |
| 口服液(元) | 11,207,245.17 | 4,834,013.12 | 14,345,955.56 | 11,253,459.59 |
| 片剂(元) | 6,331,222.70 | 3,743,887.70 | 8,424,727.86 | 4,288,740.02 |
| 原料药(元) | -120,932.59 | 99,512.13 | 995,683.29 | 863,466.64 |
| 注射剂(元) | 17,672,907.15 | 9,043,858.57 | 30,395,883.64 | 16,513,900.43 |
| 干悬混剂(元) | 1,626,236.97 | - | 2,179,715.73 | - |
| 毛利率(%) | ||||
| 干混悬剂(%) | - | 22.78 | - | 22.82 |
| 胶囊剂(%) | 95.47 | 95.55 | 93.56 | 96.80 |
| 颗粒剂(%) | 33.13 | 31.29 | 32.18 | 32.85 |
| 口服液(%) | 28.30 | 27.19 | 34.24 | 42.40 |
| 片剂(%) | 25.95 | 40.87 | 29.59 | 32.08 |
| 原料药(%) | -7.17 | 13.40 | 9.85 | 13.44 |
| 注射剂(%) | 16.01 | 15.59 | 27.84 | 34.96 |
| 干悬混剂(%) | 21.69 | - | 22.68 | - |
| 收入构成(%) | ||||
| 干混悬剂(%) | - | 4.03 | - | 4.61 |
| 胶囊剂(%) | 0.25 | 0.26 | 0.31 | 0.31 |
| 颗粒剂(%) | 12.19 | 12.90 | 10.77 | 12.11 |
| 口服液(%) | 18.89 | 17.18 | 18.70 | 23.54 |
| 片剂(%) | 11.64 | 8.85 | 12.70 | 11.86 |
| 原料药(%) | 0.81 | 0.72 | 4.51 | 5.70 |
| 注射剂(%) | 52.65 | 56.06 | 48.72 | 41.89 |
| 干悬混剂(%) | 3.58 | - | 4.29 | - |
| 毛利构成(%) | ||||
| 干混悬剂(%) | - | 4.11 | - | 3.05 |
| 胶囊剂(%) | 1.10 | 1.13 | 1.00 | 0.86 |
| 颗粒剂(%) | 18.53 | 18.07 | 11.99 | 11.52 |
| 口服液(%) | 24.53 | 20.92 | 22.15 | 28.91 |
| 片剂(%) | 13.86 | 16.20 | 13.01 | 11.02 |
| 原料药(%) | -0.26 | 0.43 | 1.54 | 2.22 |
| 注射剂(%) | 38.69 | 39.14 | 46.94 | 42.42 |
| 干悬混剂(%) | 3.56 | - | 3.37 | - |